Balance Sheet StrengthA very low debt-to-equity ratio (0.14) and a ~60.7% equity ratio indicate durable financial conservatism. This capital structure reduces refinancing and interest risks, preserves strategic optionality for store investment or M&A, and supports resilience through retail cycles over months to years.
Stable Revenue And MarginsConsistent revenue growth (~6.7% year) combined with healthy gross (25.45%) and stable operating margins (EBIT 5.55%, EBITDA 7.61%) reflects an effective retail-plus-pharmacy model. Steady top-line and margin profiles support reinvestment in stores, private labels, and margin maintenance over the medium term.
Strong Cash GenerationRobust operating cash conversion (OCF to net income 1.34) and recent FCF growth (160% increase) show durable cash-generative operations. Reliable cash flow supports dividends, capex for store expansion, and working capital needs, underpinning sustainable operational execution over months.